![]() | Only 14 pages are availabe for public view |
Abstract Myocardial infarction remains a major problem in cardiovascular medicine. Although outcomes have improved over the last 2 decades with early revascularization and modern intensive care, morbidity and mortality remain high. Predictors of mortality after the development of Myocardial infarction (MI) complicated by cardiogenic shock (MI-CS) have been evaluated in an attempt to better understand patient populations, to assist in the triage of patients for specific therapies and clinical trials, and to determine prognosis(1).in patients with early ST-elevation myocardial infarction (STEMI) (patient delay <120 min) assisted by non-capable primary percutaneous coronary intervention (PPCI) services, timely transfer for PCI within the framework of an organized STEMI network is associated with lower 30-day mortality compared with fibrinolysis. The maximum benefit was obtained in patients with first medical contact (FMC) device delay <140 min (2). There is wide heterogeneity including in the definition of acute coronary syndrome, patient populations and risk profiles, the nature of predictors evaluated, therapies available or utilized, and outcome measures(1) |